Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irun Bhan

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
JCO Precision Oncology|July 2, 2025
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular CarcinomaMaen Abdelrahim, Alejandro Mejia, Abdullah Esmail, et al.
Nature Communications|July 5, 2020
Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug targetJoseph W Franses, Julia Philipp, Pavlos Missios, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 31, 2019
Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planningEmily Bethea, Ashwini Arvind, Jenna Gustafson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinomaMark Kalinich, Irun Bhan, Tanya T Kwan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
Diagnostic Performance of PSMA PET/MRI in Characterizing LI-RADS 3 Observations in Patients with CirrhosisOnofrio Antonio Catalano, Irun Bhan, Luigi Asmundo, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2019
Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label studyEmily D Bethea, Kerry Gaj, Jenna L Gustafson, et al.
The Oncologist|February 10, 2023
Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other EtiologiesSurendra Pal Chaudhary, Stephanie Reyes, Matthew L Chase, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarkerMartin S Taylor, Wu Connie, Peter C Fridy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2024
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular CarcinomaNeehar D Parikh, Patricia Jones, Reena Salgia, et al.
Cancer Discovery|September 12, 2023
Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer BiomarkerMartin S Taylor, Connie Wu, Peter C Fridy, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
JCO Precision Oncology|July 2, 2025
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular CarcinomaMaen Abdelrahim, Alejandro Mejia, Abdullah Esmail, et al.
Nature Communications|July 5, 2020
Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug targetJoseph W Franses, Julia Philipp, Pavlos Missios, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 31, 2019
Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planningEmily Bethea, Ashwini Arvind, Jenna Gustafson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinomaMark Kalinich, Irun Bhan, Tanya T Kwan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
Diagnostic Performance of PSMA PET/MRI in Characterizing LI-RADS 3 Observations in Patients with CirrhosisOnofrio Antonio Catalano, Irun Bhan, Luigi Asmundo, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2019
Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label studyEmily D Bethea, Kerry Gaj, Jenna L Gustafson, et al.
The Oncologist|February 10, 2023
Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other EtiologiesSurendra Pal Chaudhary, Stephanie Reyes, Matthew L Chase, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarkerMartin S Taylor, Wu Connie, Peter C Fridy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2024
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular CarcinomaNeehar D Parikh, Patricia Jones, Reena Salgia, et al.
Cancer Discovery|September 12, 2023
Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer BiomarkerMartin S Taylor, Connie Wu, Peter C Fridy, et al.
Pageof 3